Magnetic device for treating corneal exposure due to eyelid paralysis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the use of a self-adhering magnetic device to treat corneal exposure resulting from paralytic lagophthalmos, a condition where patients cannot fully close their eyelids due to nerve paralysis. The study aims to evaluate the effectiveness of this innovative magnetic system in maintaining eyelid closure, thereby preventing complications such as corneal ulceration and potential blindness. By utilizing advancements in magnetic technology, the trial seeks to provide a more effective and aesthetically pleasing alternative to existing treatments, which often have limited success and poor patient compliance.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Males and females ages 18-80 years old.
* Patients with recent corneal abrasion and no signs of infection in the examination
* Patients with lagophthalmos
* Normal Controls

Exclusion Criteria:

* Individuals with adhesive or tape allergies.
* Individuals with a history of metal pieces/shavings embedded in the eye (such as from welding or metalworking)
* Individuals with eye infections

Where it's running

• University of Illinois - Specialty Care Building
  Chicago, Illinois, United States Recruiting

Study contacts

• Study coordinator: Van Ann Tran, MD
• Email: annqtran@uic.edu
• Phone: 312-996-9120

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Plastic lid spring for eyelid closure in patients with facial nerve palsy

  This study is testing a new eyelid spring to help people with facial nerve palsy keep their eyes closed better and more comfortably.

  Recruiting Early Phase 1 University of Alberta · Edmonton, Alberta and 1 other locations · NCT06895902

• Bridge & Friends: MedDiet with Social Networks for obesity in older adults

  This study tests whether adding a social network component to a Mediterranean diet with weight loss helps older adults with obesity lose more weight and improve diet and activity.

  Recruiting University of Illinois Chicago · Chicago, Illinois · NCT07798557

• BRIDGE: Embedding consumer mHealth tools into cardiac rehab

  This study tests whether adding a mobile health tool to standard center-based cardiac rehab helps heart patients stay active and follow healthy habits.

  Recruiting University of Illinois Chicago · Chicago, Illinois · NCT07741396

• Meditation app feasibility for youth in the juvenile legal system

  This study tests whether teens in probation can stick with a 1-month meditation app, comparing Bodhi AIM to a healthy-choices app across four juvenile programs.

  Recruiting University of Illinois Chicago · Chicago, Illinois · NCT07674303

• Tele-Cross Education for severe stroke

  This study tests whether home-based, remotely guided training of the unaffected leg can help improve brain and nerve function and movement in people with severe stroke.

  Recruiting University of Illinois Chicago · Chicago, Illinois · NCT07652970

• Elranatamab consolidation for newly diagnosed plasmablastic lymphoma

  This study tests whether giving Elranatamab after initial chemotherapy can help patients with plasmablastic lymphoma, with or without HIV, stay in remission.

  Recruiting Phase 1 University of Illinois Chicago · Chicago, Illinois · NCT07647432

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.